中国药物与临床
中國藥物與臨床
중국약물여림상
CHINESE REMEDIES & CLINICS
2014年
7期
891-894
,共4页
陈焱%许红苗%莫文元%俞诚波%林晡%尹向鹏
陳焱%許紅苗%莫文元%俞誠波%林晡%尹嚮鵬
진염%허홍묘%막문원%유성파%림포%윤향붕
牙周膜%成纤维细胞%脂多糖类%牙周病学%TRAF-2
牙週膜%成纖維細胞%脂多糖類%牙週病學%TRAF-2
아주막%성섬유세포%지다당류%아주병학%TRAF-2
Periodontal ligament%Fibroblasts%Lipopolysaccharide%Periodontics%Tumor necrosis factor re-ceptor-associated factor 2
目的:观察脂多糖对人牙周膜成纤维细胞(HPLFs)肿瘤坏死因子受体相关因子2(TRAF-2)的诱导作用及抗肿瘤坏死因子单抗(抗TNF单抗)对其的影响,探讨TRAF-2参与牙周病的可能作用机制。方法牙周膜成纤维细胞培养至第6代,加入不同浓度的脂多糖(0、0.1、1、10、100μg/ml)培养24 h,分别命名为Z0组、Z0.1组、Z1组、Z10组、Z100组,并取Z1组浓度的脂多糖,在加药的同时加抗TNF单抗75μg/ml( Z1+75组)。分别采用实时荧光定量聚合酶链反应(PCR)法和蛋白印迹法测定TRAF-2 mRNA及蛋白的表达。结果 Z1组、Z10组和Z100组(依次为:2.92±0.49,2.84±1.56,2.76±0.61)HPLFs TRAF-2 mRNA的表达水平显著高于Z0组或Z0.1组(依次为:1,2.17±0.27)(均P<0.05),Z1组、Z10组、Z100组3组之间和Z0组、Z0.1组2组之间差异均无统计学意义(均P>0.05)。TRAF-2蛋白的表达水平在Z0组<Z0.1组或Z100组<Z1组<Z10组(依次为:0.14±0.01,0.89±0.01,0.81±0.05,1.22±0.04,1.56±0.03)(均P<0.01),Z0.1组和Z100组之间差异无统计学意义(P>0.05)。 Z1+75组(依次为:1.51±0.22,0.05±0.01)TRAF-2 mRNA及蛋白的表达水平显著低于Z1组(分别为:P<0.05,P<0.01)。结论脂多糖能诱导HPLFs TRAF-2的表达,且随脂多糖的浓度变化而变化,这种诱导作用能被抗TNF单抗所抑制。
目的:觀察脂多糖對人牙週膜成纖維細胞(HPLFs)腫瘤壞死因子受體相關因子2(TRAF-2)的誘導作用及抗腫瘤壞死因子單抗(抗TNF單抗)對其的影響,探討TRAF-2參與牙週病的可能作用機製。方法牙週膜成纖維細胞培養至第6代,加入不同濃度的脂多糖(0、0.1、1、10、100μg/ml)培養24 h,分彆命名為Z0組、Z0.1組、Z1組、Z10組、Z100組,併取Z1組濃度的脂多糖,在加藥的同時加抗TNF單抗75μg/ml( Z1+75組)。分彆採用實時熒光定量聚閤酶鏈反應(PCR)法和蛋白印跡法測定TRAF-2 mRNA及蛋白的錶達。結果 Z1組、Z10組和Z100組(依次為:2.92±0.49,2.84±1.56,2.76±0.61)HPLFs TRAF-2 mRNA的錶達水平顯著高于Z0組或Z0.1組(依次為:1,2.17±0.27)(均P<0.05),Z1組、Z10組、Z100組3組之間和Z0組、Z0.1組2組之間差異均無統計學意義(均P>0.05)。TRAF-2蛋白的錶達水平在Z0組<Z0.1組或Z100組<Z1組<Z10組(依次為:0.14±0.01,0.89±0.01,0.81±0.05,1.22±0.04,1.56±0.03)(均P<0.01),Z0.1組和Z100組之間差異無統計學意義(P>0.05)。 Z1+75組(依次為:1.51±0.22,0.05±0.01)TRAF-2 mRNA及蛋白的錶達水平顯著低于Z1組(分彆為:P<0.05,P<0.01)。結論脂多糖能誘導HPLFs TRAF-2的錶達,且隨脂多糖的濃度變化而變化,這種誘導作用能被抗TNF單抗所抑製。
목적:관찰지다당대인아주막성섬유세포(HPLFs)종류배사인자수체상관인자2(TRAF-2)적유도작용급항종류배사인자단항(항TNF단항)대기적영향,탐토TRAF-2삼여아주병적가능작용궤제。방법아주막성섬유세포배양지제6대,가입불동농도적지다당(0、0.1、1、10、100μg/ml)배양24 h,분별명명위Z0조、Z0.1조、Z1조、Z10조、Z100조,병취Z1조농도적지다당,재가약적동시가항TNF단항75μg/ml( Z1+75조)。분별채용실시형광정량취합매련반응(PCR)법화단백인적법측정TRAF-2 mRNA급단백적표체。결과 Z1조、Z10조화Z100조(의차위:2.92±0.49,2.84±1.56,2.76±0.61)HPLFs TRAF-2 mRNA적표체수평현저고우Z0조혹Z0.1조(의차위:1,2.17±0.27)(균P<0.05),Z1조、Z10조、Z100조3조지간화Z0조、Z0.1조2조지간차이균무통계학의의(균P>0.05)。TRAF-2단백적표체수평재Z0조<Z0.1조혹Z100조<Z1조<Z10조(의차위:0.14±0.01,0.89±0.01,0.81±0.05,1.22±0.04,1.56±0.03)(균P<0.01),Z0.1조화Z100조지간차이무통계학의의(P>0.05)。 Z1+75조(의차위:1.51±0.22,0.05±0.01)TRAF-2 mRNA급단백적표체수평현저저우Z1조(분별위:P<0.05,P<0.01)。결론지다당능유도HPLFs TRAF-2적표체,차수지다당적농도변화이변화,저충유도작용능피항TNF단항소억제。
Objective To investigate the effects of lipopolysaccharide on secretion of tumor necrosis factor re-ceptor-associated factor-2 (TRAF2) and the regulation by anti-tumor necrosis factor (TNF) antibody on lipopolysaccha-ride-induced TRAF2 expression of human periodontal ligament fibroblasts (HPLFs), thus exploring the putative mech-anisms of TRAF-2 in the pathogenesis of periodontal diseases. Methods HPLFs were cultured to the sixth genera-tion and incubated with various concentrations of lipopolysaccharide (0, 0.1, 1, 10 and 100 ug/ml) for 24h (groups Z0, Z0.1, Z1, Z10 and Z100). The Z1 group was incubated with 75 μg/ml anti-TNF antibody (group Z1+75). The expres-sions of TRAF-2 mRNA and protein were analyzed by real-time quantitative reverse transcription polymerase chain reaction and Western blotting assay. Results The expressions of TRAF-2 mRNA in groups Z1, Z10 and Z100 (2.92± 0.49, 2.84±1.56 and 2.76±0.61) were significantly higher than those in groups Z0 and Z0.1 (1.00 and 2.17 ±0.27, all P<0.05). However, the difference in TRAF-2 mRNA expression among groups Z1, Z10 and Z100 and between group Z0 and Z0.1 was unremarkable (all P>0.05). The expression level of TRAF-2 protein was 0.14 ±0.01 in group Z0, 0.89±0.01 in group Z0.1, 0.81±0.05 in group Z100, 1.22±0.04 in group Z1, and 1.56±0.03 in group Z10, respectively (all P<0.01). The between-group differences were significant except for between group Z0.1 and Z100 ( P>0.05). Fur-thermore, expression levels of TRAF-2 mRNA and protein in group Z1+75 (1.51±0.22 and 0.05±0.01) were signifi-cantly lower than those in group Z1 (P<0.05 and P<0.01). Conclusion TRAF-2 expressions in HPLFs can be in-duced by lipopolysaccharide. Chnages in TRAF-2 expression with different concentrations of lipopolysaccharide can be abrogated by anti-TNF antibody.